| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |